by
Gus Iversen, Editor in Chief | July 21, 2025
Royal Philips has introduced a new digital platform designed to streamline access to AI-based electrocardiogram (ECG) tools for cardiac care teams.
The ECG AI Marketplace brings together offerings from multiple vendors into one integrated system for hospitals and health systems using Philips’ infrastructure.
Anumana, a health tech firm focused on AI-powered cardiac diagnostics, is the first company to have a certified solution available through the platform. Its FDA-cleared algorithm for detecting low ejection fraction (LEF) — a key indicator of heart failure — is now available across Philips' ECG suite, including IntelliSpace ECG and its cardiograph systems.
Ad Statistics
Times Displayed: 357
Times Visited: 1 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
The LEF algorithm uses data from standard 12-lead resting ECGs to identify signs of reduced heart function earlier in the care process. According to Anumana, the technology has been studied in over 150,000 patients and supported by close to 100 peer-reviewed publications.
“We’re proud to be the flagship offering on the Philips ECG AI Marketplace,” said Simos Kedikoglou, M.D., president and chief operating officer at Anumana. “Working with Philips expands access to our ECG-AI technology through a trusted platform, starting with our cleared LEF algorithm and extending to our full suite of point-of-care algorithms as they receive FDA regulatory clearance.”
Philips said the Marketplace was created in response to growing demand from hospitals using multiple AI tools across different platforms. By consolidating these tools under one system, the platform aims to reduce the operational burden on hospital IT teams while supporting faster diagnosis and improved clinical decision-making.
“Through the Philips ECG AI Marketplace, we’re building a more flexible and connected approach to innovation in cardiac care,” said Stefano Folli, business leader for ambulatory monitoring and diagnostics at Philips.
The Netherlands-based company said the launch marks an ongoing effort to open its ECG ecosystem to external developers and AI solutions.
